You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Spinal conditions

Risdiplam for treating spinal muscular atrophy

  • Technology appraisal guidance
  • Reference number: TA755
  • Published:  16 December 2021
  • Last updated:  15 December 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Education
  2. Resource impact
  3. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Education

  • Questions and answers on the managed access agreement for risdiplam (January 2022)

  • Appendix A: Using other treatments after onasemnogene (PDF 124 KB)

    Published:
    15 December 2023
  • Appendix B: Managed access patient agreement form (PDF 88 KB)

    Published:
    15 December 2023
  • Managed access agreement (PDF 405 KB)

    Published:
    15 December 2023

Resource impact

  • Resource impact statement

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top